Market by Therapeutic Application, Technology, Treatment Type, Product, Application, and Geography | Forecast 2021-2028
The detailed analysis of the global stem cell market shows that, in terms of revenue, the market is predicted to grow at a CAGR of 7.54% during the assessed years 2021-2028. In 2020, the market acquired revenue worth $9382 million, and is anticipated to garner $16782.2 million by 2028.
Report scope can be customized per your requirements. Request For Customization
Stem cells have
tremendous potential for cutaneous tissue regeneration, and promoting wound
repair in a paracrine manner. The occurrences of chronic conditions are surging
worldwide, owing to the rapidly aging population and greater longevity of
people with chronic diseases. This has laid tremendous pressure on the
healthcare system globally, thereby promoting the stem cell market's growth.
The stem cell market is
not well-established in several therapeutic areas. However, it holds immense
potential in diagnosis and therapeutic fields, with stem cell banking gaining
importance with supportive government initiatives. Additionally, the number of
stem cell banks has significantly grown in emerging economies, further aiding the
growth of stem cell therapies.
The study aims to get
an overview of the stem cell market in terms of various factors. Within this
report, the key insight and the market summary regarding the stem cell market
have been discussed. Further, industry components; legal, policy, &
regulatory framework; the impact of COVID-19 on the market; key impact
analysis; market attractiveness index; and vendor scorecard have been studied
in depth.
Furthermore, the
growing awareness about umbilical cord stem cells, a surge in stem cell
research and development, and rising demand for regenerative medicine are key
factors driving the stem cell market's progress. However, the ethical concerns
associated with stem cells, the elevated cost of stem cell procedures, and
stringent regulation relating to stem cell therapy, are restraints obstructing
the studied market's development.
Nevertheless, opportunities such as technological advancement, along with the risk of adverse immune reactions and complications, can be leveraged by the stem cell market to reach its anticipated growth.
Geographies
covered in the global stem cell market are:
• North America: United States and
Canada
• Europe: United Kingdom, Germany,
France, Italy, Spain, Russia, and Rest of Europe
• Asia-Pacific: China, Japan, South
Korea, India, ASEAN countries, New Zealand & Australia, and Rest of
Asia-Pacific
• Latin America: Mexico, Brazil, and
Rest of Latin America
• Middle East and Africa: Israel, Turkey,
United Arab Emirates, South Africa, Saudi Arabia, and Rest of Middle East &
Africa
The
segmentation analysis of the stem cell market, in this report, includes:
• Market by Therapeutic Application:
o Neurological
Disorders
o Oncology
Disorders
o Diabetes
o Injuries
and Wounds
o Orthopedic
Treatments
o Cardiovascular
Disorders
o Other
Therapeutic Applications
• Market by Technology:
o Cryopreservation
o Acquisition
• Stem Cell Apheresis
• Stem
Cell Bone Marrow Market
• Stem Cell Umbilical Cord
o Expansion
and Sub-Culture
o Production
• Stem Cell Culture
• Therapeutic Cloning
• IVF
• Market by Treatment Type:
o Allogeneic
Stem Cell Therapy
o Autologic
Stem Cell Therapy
o Syngeneic
Stem Cell Therapy
• Market by Product:
o Adult
Stem Cell
• Hematopoietic Stem Cell
• Neural Stem Cell
• Umbilical Cord Stem Cell
• Mesenchymal Stem Cell
• Dental Stem Cell
o Human
Embryonic Stem Cell
o Pluripotent
o Mouse/Rat
Neural
• Market by Application:
o Regenerative
Medicine
o Drug
Discovery and Development
The key players engaged
in the stem cell market are International Stem Cell Corp, GE Healthcare, Thermo
Fisher Scientific Inc, Merck KGAA (Sigma Aldrich), Qiagen NV, Pluristem
Therapeutics Inc, StemCell Technologies, Smith & Nephew Plc, AllCells LLC, Stryker
Corporation, Takara Holdings, Corning Inc, Cytori Therapeutics, Becton
Dickinson and Company (BD), and Miltenyi Biotec.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
STEM CELL MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. PORTER’S
FIVE FORCES MODEL
2.1.1. THREAT
OF NEW ENTRANTS
2.1.2. THREAT
OF SUBSTITUTE PRODUCTS
2.1.3. BARGAINING
POWER OF BUYERS
2.1.4. BARGAINING
POWER OF SUPPLIERS
2.1.5. COMPETITIVE
RIVALRY
2.2. IMPACT
OF COVID-19 ON STEM CELL MARKET
2.3. KEY
IMPACT ANALYSIS
2.4. INDUSTRY
COMPONENTS
2.5. LEGAL,
POLICY, & REGULATORY FRAMEWORK
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. VENDOR
SCORECARD
2.8. KEY
INSIGHTS
2.9. MARKET
DRIVERS
2.9.1. GROWING
AWARENESS ABOUT UMBILICAL CORD STEM CELLS
2.9.2. SURGE
IN STEM CELL RESEARCH AND DEVELOPMENT
2.9.3. RISING
DEMAND FOR REGENERATIVE MEDICINE
2.10. MARKET RESTRAINTS
2.10.1. ETHICAL CONCERNS ASSOCIATED
WITH STEM CELLS
2.10.2. HIGH COST OF STEM CELL
PROCEDURES
2.10.3. STRINGENT REGULATIONS IN TERMS
OF STEM CELL THERAPY
2.11. MARKET OPPORTUNITIES
2.11.1. ADVANCEMENT IN TECHNOLOGY
2.11.2. RISK OF ADVERSE IMMUNE
REACTIONS AND COMPLICATIONS
3. GLOBAL
STEM CELL MARKET OUTLOOK - BY THERAPEUTIC APPLICATION
3.1. NEUROLOGICAL
DISORDERS
3.2. ONCOLOGY
DISORDERS
3.3. DIABETES
3.4. INJURIES
AND WOUNDS
3.5. ORTHOPEDIC
TREATMENTS
3.6. CARDIOVASCULAR
DISORDERS
3.7. OTHER
THERAPEUTIC APPLICATIONS
4. GLOBAL
STEM CELL MARKET OUTLOOK - BY TECHNOLOGY
4.1. CRYOPRESERVATION
4.2. ACQUISITION
4.2.1. STEM
CELL APHERESIS
4.2.2. STEM
CELL BONE MARROW MARKET
4.2.3. STEM
CELL UMBILICAL CORD
4.3. EXPANSION
AND SUB-CULTURE
4.4. PRODUCTION
4.4.1. STEM
CELL CULTURE
4.4.2. THERAPEUTIC
CLONING
4.4.3. IVF
5. GLOBAL
STEM CELL MARKET OUTLOOK - BY TREATMENT TYPE
5.1. ALLOGENEIC
STEM CELL THERAPY
5.2. AUTOLOGIC
STEM CELL THERAPY
5.3. SYNGENEIC
STEM CELL THERAPY
6. GLOBAL
STEM CELL MARKET OUTLOOK - BY PRODUCT
6.1. ADULT
STEM CELL
6.1.1. HEMATOPOIETIC
STEM CELL
6.1.2. NEURAL
STEM CELL
6.1.3. UMBILICAL
CORD STEM CELL
6.1.4. MESENCHYMAL
STEM CELL
6.1.5. DENTAL
STEM CELL
6.2. HUMAN
EMBRYONIC STEM CELL
6.3. PLURIPOTENT
6.4. MOUSE/RAT
NEURAL
7. GLOBAL
STEM CELL MARKET OUTLOOK - BY APPLICATION
7.1. REGENERATIVE
MEDICINE
7.2. DRUG
DISCOVERY AND DEVELOPMENT
8. GLOBAL
STEM CELL MARKET - REGIONAL OUTLOOK
8.1. NORTH
AMERICA
8.1.1. MARKET
BY THERAPEUTIC APPLICATION
8.1.2. MARKET
BY TECHNOLOGY
8.1.2.1. MARKET
BY ACQUISITION
8.1.2.2. MARKET
BY PRODUCTION
8.1.3. MARKET
BY TREATMENT TYPE
8.1.4. MARKET
BY PRODUCT
8.1.4.1. ADULT
STEM CELL MARKET BY TYPE
8.1.5. MARKET
BY APPLICATION
8.1.6. COUNTRY
ANALYSIS
8.1.6.1. UNITED
STATES
8.1.6.2. CANADA
8.2. EUROPE
8.2.1. MARKET
BY THERAPEUTIC APPLICATION
8.2.2. MARKET
BY TECHNOLOGY
8.2.2.1. MARKET
BY ACQUISITION
8.2.2.2. MARKET
BY PRODUCTION
8.2.3. MARKET
BY TREATMENT TYPE
8.2.4. MARKET
BY PRODUCT
8.2.4.1. ADULT
STEM CELL MARKET BY TYPE
8.2.5. MARKET
BY APPLICATION
8.2.6. COUNTRY
ANALYSIS
8.2.6.1. GERMANY
8.2.6.2. FRANCE
8.2.6.3. UNITED
KINGDOM
8.2.6.4. ITALY
8.2.6.5. RUSSIA
8.2.6.6. SPAIN
8.2.6.7. REST
OF EUROPE
8.3. ASIA-PACIFIC
8.3.1. MARKET
BY THERAPEUTIC APPLICATION
8.3.2. MARKET
BY TECHNOLOGY
8.3.2.1. MARKET
BY ACQUISITION
8.3.2.2. MARKET
BY PRODUCTION
8.3.3. MARKET
BY TREATMENT TYPE
8.3.4. MARKET
BY PRODUCT
8.3.4.1. ADULT
STEM CELL MARKET BY TYPE
8.3.5. MARKET
BY APPLICATION
8.3.6. COUNTRY
ANALYSIS
8.3.6.1. CHINA
8.3.6.2. JAPAN
8.3.6.3. INDIA
8.3.6.4. AUSTRALIA
& NEW ZEALAND
8.3.6.5. SOUTH
KOREA
8.3.6.6. ASEAN
COUNTRIES
8.3.6.7. REST
OF ASIA-PACIFIC
8.4. LATIN
AMERICA
8.4.1. MARKET
BY THERAPEUTIC APPLICATION
8.4.2. MARKET
BY TECHNOLOGY
8.4.2.1. MARKET
BY ACQUISITION
8.4.2.2. MARKET
BY PRODUCTION
8.4.3. MARKET
BY TREATMENT TYPE
8.4.4. MARKET
BY PRODUCT
8.4.4.1. ADULT
STEM CELL MARKET BY TYPE
8.4.5. MARKET
BY APPLICATION
8.4.6. COUNTRY
ANALYSIS
8.4.6.1. MEXICO
8.4.6.2. BRAZIL
8.4.6.3. REST
OF LATIN AMERICA
8.5. MIDDLE
EAST AND AFRICA
8.5.1. MARKET
BY THERAPEUTIC APPLICATION
8.5.2. MARKET
BY TECHNOLOGY
8.5.2.1. MARKET
BY ACQUISITION
8.5.2.2. MARKET
BY PRODUCTION
8.5.3. MARKET
BY TREATMENT TYPE
8.5.4. MARKET
BY PRODUCT
8.5.4.1. ADULT
STEM CELL MARKET BY TYPE
8.5.5. MARKET
BY APPLICATION
8.5.6. COUNTRY ANALYSIS
8.5.6.1. ISRAEL
8.5.6.2 SAUDI ARABIA
8.5.6.3. UNITED
ARAB EMIRATES
8.5.6.4. TURKEY
8.5.6.5. SOUTH
AFRICA
8.5.6.6. REST
OF MIDDLE EAST & AFRICA
9. COMPANY
PROFILES
9.1. CORNING
INC
9.2. STEMCELL
TECHNOLOGIES
9.3. STRYKER
CORPORATION
9.4. BECTON
DICKINSON AND COMPANY (BD)
9.5. CYTORI
THERAPEUTICS
9.6. QIAGEN
NV
9.7. GE
HEALTHCARE
9.8. TAKARA
HOLDINGS
9.9. SMITH
& NEPHEW PLC
9.10. INTERNATIONAL STEM CELL CORP
9.11. MILTENYI BIOTEC
9.12. MERCK KGAA (SIGMA ALDRICH)
9.13. THERMOFISHER SCIENTIFIC INC
9.14. ALLCELLS LLC
9.15. PLURISTEM THERAPEUTICS INC
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH SCOPE &
DELIVERABLES
10.1.1. OBJECTIVES OF STUDY
10.1.2. SCOPE OF STUDY
10.2. SOURCES OF DATA
10.2.1. PRIMARY DATA SOURCES
10.2.2. SECONDARY DATA SOURCES
10.3. RESEARCH METHODOLOGY
10.3.1. EVALUATION OF PROPOSED MARKET
10.3.2. IDENTIFICATION OF DATA SOURCES
10.3.3. ASSESSMENT OF MARKET
DETERMINANTS
10.3.4. DATA COLLECTION
10.3.5. DATA VALIDATION & ANALYSIS
TABLE 1 GLOBAL
STEM CELL MARKET, BY REGION, 2021-2028 (IN $ MILLION)
TABLE 2 VENDOR
SCORECARD
TABLE 3 GLOBAL
STEM CELL MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 4 GLOBAL
STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 5 GLOBAL
ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 6 GLOBAL
PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 7 GLOBAL
STEM CELL MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 8 GLOBAL
STEM CELL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 9 GLOBAL
ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 10 GLOBAL
STEM CELL MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 11 GLOBAL
STEM CELL MARKET, BY REGION, 2021-2028 (IN $ MILLION)
TABLE 12 NORTH
AMERICA STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 13 NORTH
AMERICA STEM CELL MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 14 NORTH
AMERICA STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 15 NORTH
AMERICA ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 16 NORTH
AMERICA PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 17 NORTH
AMERICA STEM CELL, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 18 NORTH
AMERICA STEM CELL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 19 NORTH
AMERICA ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 20 NORTH
AMERICA STEM CELL MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 21 EUROPE
STEM CELL, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 22 EUROPE
STEM CELL MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 23 EUROPE
STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 24 EUROPE
ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 25 EUROPE
PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 26 EUROPE
STEM CELL, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 27 EUROPE
STEM CELL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 28 EUROPE
ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 29 EUROPE
STEM CELL MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 30 ASIA-PACIFIC
STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 31 ASIA-PACIFIC
STEM CELL MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 32 ASIA-PACIFIC
STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 33 ASIA-PACIFIC
ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 34 ASIA-PACIFIC
PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 35 ASIA-PACIFIC
STEM CELL, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 36 ASIA-PACIFIC
STEM CELL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 37 ASIA-PACIFIC
ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 38 ASIA-PACIFIC
STEM CELL MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 39 LATIN
AMERICA STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 40 LATIN
AMERICA STEM CELL MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 41 LATIN
AMERICA STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 42 LATIN
AMERICA ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 43 LATIN
AMERICA PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 44 LATIN
AMERICA STEM CELL, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 45 LATIN
AMERICA STEM CELL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 46 LATIN AMERICA
ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 47 LATIN
AMERICA STEM CELL MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 48 MIDDLE
EAST AND AFRICA STEM CELL MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 49 MIDDLE
EAST AND AFRICA STEM CELL MARKET, BY THERAPEUTIC APPLICATION, 2021-2028 (IN $
MILLION)
TABLE 50 MIDDLE
EAST AND AFRICA STEM CELL MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 51 MIDDLE
EAST AND AFRICA ACQUISITION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 52 MIDDLE
EAST AND AFRICA PRODUCTION MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 53 MIDDLE
EAST AND AFRICA STEM CELL, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 54 MIDDLE
EAST AND AFRICA STEM CELL MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 55 MIDDLE
EAST AND AFRICA ADULT STEM CELL MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 56 MIDDLE
EAST AND AFRICA STEM CELL MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
FIGURE 1 GLOBAL
STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 2 GLOBAL
STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 3 GLOBAL
STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 4 GLOBAL
STEM CELL MARKET, BY DIABETES, 2021-2028 (IN $ MILLION)
FIGURE 5 GLOBAL
STEM CELL MARKET, BY INJURIES AND WOUNDS, 2021-2028 (IN $ MILLION)
FIGURE 6 GLOBAL
STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2021-2028 (IN $ MILLION)
FIGURE 7 GLOBAL
STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE 8 GLOBAL
STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 9 GLOBAL
STEM CELL MARKET, BY CRYOPRESERVATION, 2021-2028 (IN $ MILLION)
FIGURE 10 GLOBAL
STEM CELL MARKET, BY ACQUISITION, 2021-2028 (IN $ MILLION)
FIGURE 11 GLOBAL
STEM CELL MARKET, BY STEM CELL APHERESIS, 2021-2028 (IN $ MILLION)
FIGURE 12 GLOBAL
STEM CELL MARKET, BY STEM CELL BONE MARROW MARKET, 2021-2028 (IN $ MILLION)
FIGURE 13 GLOBAL
STEM CELL MARKET, BY STEM CELL UMBILICAL CORD, 2021-2028 (IN $ MILLION)
FIGURE 14 GLOBAL
STEM CELL MARKET, BY EXPANSION AND SUB-CULTURE, 2021-2028 (IN $ MILLION)
FIGURE 15 GLOBAL
STEM CELL MARKET, BY PRODUCTION, 2021-2028 (IN $ MILLION)
FIGURE 16 GLOBAL
STEM CELL MARKET, BY STEM CELL CULTURE, 2021-2028 (IN $ MILLION)
FIGURE 17 GLOBAL
STEM CELL MARKET, BY THERAPEUTIC CLONING, 2021-2028 (IN $ MILLION)
FIGURE 18 GLOBAL
STEM CELL MARKET, BY IVF, 2021-2028 (IN $ MILLION)
FIGURE 19 GLOBAL
STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 20 GLOBAL
STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 21 GLOBAL
STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 22 GLOBAL
STEM CELL MARKET, BY ADULT STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 23 GLOBAL STEM
CELL MARKET, BY HEMATOPOIETIC STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 24 GLOBAL
STEM CELL MARKET, BY NEURAL STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 25 GLOBAL
STEM CELL MARKET, BY UMBILICAL CORD STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 26 GLOBAL
STEM CELL MARKET, BY MESENCHYMAL STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 27 GLOBAL
STEM CELL MARKET, BY DENTAL STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 28 GLOBAL
STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2021-2028 (IN $ MILLION)
FIGURE 29 GLOBAL
STEM CELL MARKET, BY PLURIPOTENT, 2021-2028 (IN $ MILLION)
FIGURE 30 GLOBAL
STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2021-2028 (IN $ MILLION)
FIGURE 31 GLOBAL
STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2021-2028 (IN $ MILLION)
FIGURE 32 GLOBAL
STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2021-2028 (IN $ MILLION)
FIGURE 33 UNITED
STATES STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 34 CANADA
STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 35 GERMANY
STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 36 FRANCE
STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 37 UNITED
KINGDOM STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 38 ITALY STEM
CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 39 RUSSIA
STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 40 SPAIN STEM
CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 41 REST OF
EUROPE STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 42 CHINA STEM
CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 43 JAPAN STEM
CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 44 INDIA STEM
CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 45 AUSTRALIA
& NEW ZEALAND STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 46 SOUTH
KOREA STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 47 ASEAN
COUNTRIES STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 48 REST OF ASIA-PACIFIC
STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 49 MEXICO
STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 50 BRAZIL
STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 51 REST OF LATIN AMERICA STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 52 ISRAEL STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 53 SAUDI
ARABIA STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 54 UNITED
ARAB EMIRATES STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 55 TURKEY
STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 56 SOUTH
AFRICA STEM CELL MARKET 2021-2028 (IN $ MILLION)
FIGURE 57 REST OF
MIDDLE EAST & AFRICA STEM CELL MARKET 2021-2028 (IN $ MILLION)